220127-57-1
![](https://bulatpharmaceutical.com/wp-content/uploads/2021/05/1200px-Imatinib2DACS.svg_.png)
Enquire Now
Product CAS No
Product Description
Imatinib mesylate belongs to the signal transduction inhibitor category of targeted therapies. It is particularly a protein-tyrosine kinase inhibitor.
Therapeutic Action
Imatinib is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases).